ArticleHarvard data science review2022

Evaluating Personalized (N-of-1) Trials in Rare Diseases: How Much Experimentation Is Enough?

Ken Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.